Search results for " press"

showing 10 items of 4213 documents

Effects of amlodipine on renal haemodynamics in mild to moderate hypertensive patients. A randomized controlled study versus placebo.

1993

In this study the efficacy and safety of short-term amlodipine administration on renal haemodynamics were evaluated in mild to moderate hypertensive subjects. Our final goal was to evaluate whether the reduced blood pressure induced by treatment was associated with maintenance of renal function. After a run-in period with placebo, 30 hypertensive patients without cardiac or renal diseases were randomly allocated to a double-blind 4 weeks controlled study with amlodipine 10 mg once a day (15 patients) or placebo (15 patients). Renal haemodynamic measurements included effective renal plasma flow (ERPF) and glomerular filtration rate (GFR) by radionuclide study using 131I-hippuran and 99mTc, w…

AdultMalemedicine.medical_specialtyRenal Blood Flow Effectivemedicine.medical_treatmentRenal functionPlacebolaw.inventionRandomized controlled trialDouble-Blind MethodlawReninmedicineHumansPharmacology (medical)AmlodipinePharmacologyChemotherapybusiness.industryGeneral MedicineMiddle AgedSurgeryClinical trialUrodynamicsBlood pressureAnesthesiaRenal blood flowHypertensionFemaleVascular ResistanceAmlodipinebusinessmedicine.drugGlomerular Filtration RateEuropean journal of clinical pharmacology
researchProduct

Human corticotropin-releasing factor (hCRF) is a potent respiratory analeptic. Physiological and clinical aspects.

1986

During intravenous corticotropin-releasing factor stimulation tests we observed a deepening of the tidal volume in 35 patients. To investigate this presumed respiratory stimulation we measured respiratory parameters in 12 healthy male volunteers in a single-blind placebo-controlled trial. The intravenous 60-s infusion of 100 micrograms of human corticotropin-releasing factor induced a very potent respiratory stimulation in every subject: respiratory minute volume (mean +/- S.D.) increased by 81% from 6.319 +/- 0.577 to 11.464 +/- 1.264 liters per min (P less than 0.001), whereas there was only a slight rise in the mean respiratory rate from 12.4 +/- 3.0 to 14.7 +/- 2.7 breaths per min (P le…

AdultMalemedicine.medical_specialtyRespiratory rateCorticotropin-Releasing HormoneBlood PressureHeart RateInternal medicineDrug DiscoveryHeart rateHyperventilationRespirationmedicineTidal VolumeHumansRespiratory systemGenetics (clinical)Tidal volumebusiness.industryRespirationGeneral MedicineCarbon DioxideOxygenEndocrinologyAnalepticAnesthesiaMolecular Medicinemedicine.symptombusinessRespiratory minute volumeKlinische Wochenschrift
researchProduct

Human Corticotropin-Releasing Hormone in Man: Dose-Response of Minute Ventilation and End-Tidal Partial Pressures of Carbon Dioxide and Oxygen*

1987

The respiratory stimulant properties of iv injections of 33, 67, and 100 micrograms synthetic human corticotropin-releasing hormone (hCRH) were studied in 12 normal men in a single blind, placebo-controlled trial. All doses of hCRH induced a respiratory stimulation in every subject, and the stimulation was dose dependent. The onset of respiratory stimulation occurred within 15-30 sec after hCRH infusion was started. Initially, there was an increase in tidal volume (VT), followed by an increase in respiratory rate. The maximum minute ventilation (VE) occurred 60-120 sec after starting the injection. The 33-micrograms hCRH dose induced a 35% increase in VE from 6.3 +/- 0.6 (+/- SD) to 9.7 +/-…

AdultMalemedicine.medical_specialtyRespiratory rateCorticotropin-Releasing HormonePartial PressureEndocrinology Diabetes and MetabolismClinical BiochemistryBlood PressureStimulationPeptide hormoneBiochemistryEndocrinologyDouble-Blind MethodHeart RateInternal medicineHeart rateFlushingmedicineHumansRespiratory systemTidal volumeDose-Response Relationship DrugChemistryRespirationBiochemistry (medical)Carbon DioxideOxygenEndocrinologyAnesthesiaBreathingRespiratory minute volumeThe Journal of Clinical Endocrinology & Metabolism
researchProduct

Vitamin D receptor gene polymorphisms and plasma renin activity in essential hypertensive individuals.

2014

Several studies analyzed 25-hydroxyvitamin D (25[OH]D) and blood pressure (BP) relationship with mixed results. Moreover, a relationship between the risk of hypertension and vitamin D receptor (VDR) gene polymorphisms, FokI and BsmI, was reported. This study was aimed to analyze these relationships in essential hypertensive (EH) patients. Seventy-one EH patients, 18-75 years old, were enrolled. Patients underwent clinical BP, 24-h ambulatory BP monitoring, 25[OH]D and plasma renin activity (PRA) evaluations. FokI and BsmI VDR polymorphisms were analyzed and compared with those of 72 healthy controls. In EH patients, the median 25[OH]D levels were lower than 30 ng ml(-1). We found a signific…

AdultMalemedicine.medical_specialtySettore MED/09 - Medicina InternaAmbulatory blood pressureAdolescentGenotypeRenal functionBlood PressureCalcitriol receptorPlasma renin activityBody Mass IndexPlasma renin activityGene FrequencyPolymorphism (computer science)Internal medicineReninInternal MedicineMedicineHumansVitamin DAgedSettore MED/14 - NefrologiaPolymorphism Geneticbiologybusiness.industryGene polymorphismMiddle AgedFokIBlood pressureEndocrinologyHypertensionMultivariate Analysisbiology.proteinReceptors CalcitriolFemaleEssential hypertenionbusinessBody mass indexJournal of human hypertension
researchProduct

Relationship Between Short-Term Blood Pressure Variability and Subclinical Renal Damage in Essential Hypertensive Patients

2015

The authors aimed to analyze the relationship between subclinical renal damage, defined as the presence of microalbuminuria or an estimated glomerular filtration rate (eGFR) between 30 mL/min/1.73 m(2) and 60 mL/min/1.73 m(2) and short-term blood pressure (BP) variability, assessed as average real variability (ARV), weighted standard deviation (SD) of 24-hour BP, and SD of daytime and nighttime BP. A total of 328 hypertensive patients underwent 24-hour ambulatory BP monitoring, 24-hour albumin excretion rate determination, and eGFR calculation using the Chronic Kidney Disease Epidemiology Collaboration equation. ARV of 24-hour systolic BP (SBP) was significantly higher in patients with subc…

AdultMalemedicine.medical_specialtySettore MED/09 - Medicina InternaAmbulatory blood pressureEndocrinology Diabetes and MetabolismRenal functionBlood PressureEssential hypertensionrenal dysfunctionInternal medicineCKDInternal MedicineAlbuminuriaHumansMedicineSubclinical infectionSettore MED/14 - Nefrologiabusiness.industryBlood Pressure Monitoring AmbulatoryMiddle Agedmedicine.diseaseOriginal PapersSettore MED/11 - Malattie Dell'Apparato Cardiovascolareambulatory blood pressure monitoringEndocrinologyBlood pressureHypertension; blood pressure variability; renal dysfunction; CKD; albuminuria; ambulatory blood pressure monitoringHypertensionAmbulatoryCardiologyFemaleKidney DiseasesMicroalbuminuriablood pressure variabilityEssential HypertensionCardiology and Cardiovascular MedicinebusinessGlomerular Filtration RateKidney diseaseThe Journal of Clinical Hypertension
researchProduct

Left ventricular function response to exercise in normotensive obese subjects: influence of degree and duration of obesity

1992

This study has been designed to evaluate whether duration and severity of obesity can influence left ventricular function response to exercise in obese subjects without other known cardiovascular risk factors such as hypertension, diabetes or hyperlipoproteinemia. A total of 29 obese subjects were included and they were divided, according to their body mass index and to Garrow's criteria as follows: Overweight or mildly obese subjects: body mass index from 25 to 30 kg/m2; moderately obese subjects: body mass index30 and40 kg/m2. Both obese groups were further subdivided according to their duration of obesity evaluated by accurate anamnesis in subgroup A (duration of obesity less than 120 mo…

AdultMalemedicine.medical_specialtySettore MED/09 - Medicina InternaHemodynamicsPhysical exerciseOverweightVentricular Function LeftBody Mass IndexElectrocardiographyRisk FactorsLeft ventricular function obesity.Internal medicineDiabetes mellitusmedicineHumansObesityCardiac OutputEjection fractionbusiness.industryHemodynamicsMiddle Agedmedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareObesityEndocrinologyBlood pressureEchocardiographyExercise TestCardiologyFemalemedicine.symptomCardiology and Cardiovascular MedicinebusinessBody mass indexInternational Journal of Cardiology
researchProduct

Plasma Aldosterone and Its Relationships With Left Ventricular Mass in Essential Hypertensive Patients With the Metabolic Syndrome

2008

BACKGROUND: The association of aldosterone with the metabolic syndrome (MetS) has not been fully elucidated. The aim of our study was to evaluate the relationships of plasma aldosterone concentration (PAC) with MetS and left ventricular mass (LVM) in nondiabetic Caucasian patients with essential hypertension. METHODS: Measurements were taken with the patients off antihypertensive medications. The measurements included 24-h blood pressure (BP) readings, plasma renin activity (PRA) and aldosterone, and an echocardiogram. RESULTS: Subjects with MetS (n = 201) had higher age-adjusted PAC (10.2 +/- 5.8 vs. 11.6 +/- 5.9 ng/dl; P = 0.01) and greater age-adjusted LVM indexed for height2.7 (LVMH2.7)…

AdultMalemedicine.medical_specialtySettore MED/09 - Medicina InternaMegalencephalic leukoencephalopathy with subcortical cystsPopulationBlood PressureEssential hypertensionPlasma renin activitychemistry.chemical_compoundInternal medicineReninInternal MedicinemedicineHumanseducationAldosteroneMetabolic Syndromeeducation.field_of_studyAldosteronebusiness.industrymedicine.diseaseAldosterone massa ventricolare sinistra sindrome metabolica ipertensione arteriosaEndocrinologyBlood pressurechemistryEchocardiographyHypertensionFemaleHypertrophy Left VentricularMetabolic syndromebusinessBody mass indexAmerican Journal of Hypertension
researchProduct

Variable association of 24-h peripheral and central hemodynamics and stiffness with hypertension-mediated organ damage: the VASOTENS Registry.

2020

Objective In this analysis of the telehealth-based Vascular health ASsessment Of The hypertENSive patients Registry, we checked how 24-h central and peripheral hemodynamics compare with hypertension-mediated organ damage (HMOD). Methods In 646 hypertensive patients (mean age 52 ± 16 years, 54% males, 65% treated) we obtained ambulatory brachial and central SBP and pulse pressure (PP), SBP, and PP variability, pulse wave velocity and augmentation index with a validated cuff-based technology. HMOD was defined by an increased left ventricular mass index (cardiac damage, evaluated in 482 patients), an increased intima-media thickness (vascular damage, n = 368), or a decreased estimated glomerul…

AdultMalemedicine.medical_specialtySettore MED/09 - Medicina InternaPhysiologyarterial stiffness augmentation index blood pressure blood pressure telemonitoring central arterial pressure hypertension pulse wave velocity vascular biomarkersRenal functionHemodynamicsBlood Pressure030204 cardiovascular system & hematologyPulse Wave AnalysisKidneyCarotid Intima-Media Thickness03 medical and health sciences0302 clinical medicineInternal medicineInternal MedicinemedicineHumans030212 general & internal medicineRegistriesPulse wave velocityAgedSettore MED/14 - Nefrologiabusiness.industryHemodynamicsBlood Pressure DeterminationOdds ratioBlood Pressure Monitoring AmbulatoryMiddle Agedmedicine.diseasePulse pressureBlood pressureAmbulatoryHypertensionCardiologyArterial stiffnessFemaleCardiology and Cardiovascular MedicinebusinessGlomerular Filtration RateJournal of hypertension
researchProduct

Relationship between circulating E-selectin, DD genotype of angiotensin-converting-enzyme, and cardiovascular damage in central obese subjects

2003

Fifty-six young central obese patients were investigated to evaluate relationships between soluble E-selectin (sE-S), angiotensin-converting enzyme (ACE) gene polymorphism, left ventricular function and structure, and carotid morphology by determination of sE-S and ACE genotypes. Our results indicated that central obese subjects with concomitant higher levels of sE-S and ACE DD genotype may be characterized by early cardiovascular alterations and then considered a particular subset of subjects at higher risk of cardiovascular disease.

AdultMalemedicine.medical_specialtySettore MED/09 - Medicina Internaangiotensin-converting-enzyme cardiovascular damageGenotypeArteriosclerosisEndocrinology Diabetes and MetabolismBlood PressureDiseasecentral obese subjectsPeptidyl-Dipeptidase ABody Mass Indexcirculating E-selectin genotype; angiotensin-converting-enzyme cardiovascular damage; central obese subjectsEndocrinologyRisk FactorsInternal medicineGenotypeE-selectinmedicineHumansInsulinObesityAllelesbiologyVentricular functionHemodynamicsHeartAngiotensin-converting enzymeGlucose Tolerance TestSettore MED/45 - Scienze Infermieristiche Generali Cliniche E PediatricheIsoenzymesCarotid ArteriesEndocrinologyCardiovascular DiseasesEchocardiographyConcomitantbiology.proteinRegression AnalysisFemaleObese subjectsGene polymorphismE-Selectincirculating E-selectin genotypeMetabolism
researchProduct

Insulin-resistance HCV infection-related affects vascular stiffness in normotensives

2015

BACKGROUND AND AIMS. Arterial stiffness evaluated as pulse wave velocity, is an early marker of vascular damage and an independent predictor for cardiovascular events. We investigated if the insulin resistance/hyperinsulinemia chronic hepatitis C virus infection-related could influence arterial stiffness. METHODS. We enrolled 260 outpatients matched for age, body mass index, gender, ethnicity: 52 with never-treated uncomplicated chronic hepatitis C virus infection (HCV(+)), 104 never-treated hypertensives (HT) and 104 healthy subjects (NT). Pulse wave velocity was evaluated by a validated system employing high-fidelity applanation tonometry. We also measured: fasting plasma glucose and insu…

AdultMalemedicine.medical_specialtySettore MED/09 - Medicina Internamedicine.medical_treatmentArterial stiffness; Chronic hepatitis C virus infection; Insulin resistanceInsulin resistance; chronic hepatitis C virus infection; arterial stiffnessBlood PressurePulse Wave AnalysisBody Mass Indexchemistry.chemical_compoundVascular StiffnessInsulin resistanceRisk FactorsHyperinsulinismInternal medicinemedicineHyperinsulinemiaHumansInsulinPulse wave velocityCreatinineTriglyceridebusiness.industryInsulinInsulin resistanceHepatitis CHepatitis C ChronicMiddle Agedmedicine.diseaseArterial stiffnearterial stiffnessEndocrinologychemistryCase-Control StudiesHypertensionLinear ModelsArterial stiffnessFemaleCardiology and Cardiovascular MedicinebusinessChronic hepatitis C virus infection
researchProduct